Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-25-338415 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 31, 2025 |
| Document Date | Dec 31, 2025 |
| Document | View SEC Filing |
Transactions
4
Total Shares
90,000
Total Value
$2,404,339.35
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Dec 31, 2025 | Exercise/Conversion | 30,000 | $2.08 | $62,400.00 | 693,077 | Direct | โ | View Details | |
Director | Common Stock | โ | Dec 31, 2025 | Sale | 23,986 | $77.95 | $1,869,727.89 | 669,091 | Direct | โ | View Details | |
Director | Common Stock | โ | Dec 31, 2025 | Sale | 6,014 | $78.52 | $472,211.46 | 663,077 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Dec 31, 2025 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 275,559 | Direct | โ | View Details |